Eden Research (LON:EDEN) Stock Price Down 3.3% – What’s Next?

Posted by Mark Dietrich on Feb 22nd, 2025

Eden Research plc (LON:EDEN – Get Free Report)’s stock price was down 3.3% during trading on Saturday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares changed hands during mid-day trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80. The stock has a market cap of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92. The business’s 50-day moving average price is GBX 3.88 and its 200-day moving average price is GBX 3.95.

Insider Buying and Selling

In other Eden Research news, insider Alexander John Abrey acquired 540,540 shares of the company’s stock in a transaction dated Tuesday, January 28th. The shares were purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek acquired 256,000 shares of the company’s stock in a transaction dated Thursday, February 6th. The shares were acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). 14.02% of the stock is currently owned by insiders.

About Eden Research

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.